These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3290384)

  • 1. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.
    Waage A; Espevik T
    J Exp Med; 1988 Jun; 167(6):1987-92. PubMed ID: 3290384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.
    Elias JA; Lentz V
    J Immunol; 1990 Jul; 145(1):161-6. PubMed ID: 2358670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
    J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    Dinarello CA; Cannon JG; Wolff SM; Bernheim HA; Beutler B; Cerami A; Figari IS; Palladino MA; O'Connor JV
    J Exp Med; 1986 Jun; 163(6):1433-50. PubMed ID: 3486936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 and tumor necrosis factor synergistically stimulate lung fibroblast interleukin-1 alpha production.
    Elias JA; Reynolds MM
    Am J Respir Cell Mol Biol; 1990 Jul; 3(1):13-20. PubMed ID: 2363934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human rTNF alpha augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1 alpha.
    Roll JT; Young KM; Kurtz RS; Czuprynski CJ
    Immunology; 1990 Feb; 69(2):316-22. PubMed ID: 2307486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.
    Mortensen RF; Shapiro J; Lin BF; Douches S; Neta R
    J Immunol; 1988 Apr; 140(7):2260-6. PubMed ID: 2450915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human recombinant tumor necrosis factor-alpha and interleukin 1 on the synthesis of glycosaminoglycan and DNA in cultured rat costal chondrocytes.
    Ikebe T; Hirata M; Koga T
    J Immunol; 1988 Feb; 140(3):827-31. PubMed ID: 3257505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep.
    Shoham S; Davenne D; Cady AB; Dinarello CA; Krueger JM
    Am J Physiol; 1987 Jul; 253(1 Pt 2):R142-9. PubMed ID: 3496800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor.
    Quagliarello VJ; Wispelwey B; Long WJ; Scheld WM
    J Clin Invest; 1991 Apr; 87(4):1360-6. PubMed ID: 2010549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in mice.
    Brouckaert PG; Everaerdt B; Libert C; Takahashi N; Fiers W
    Agents Actions; 1989 Jan; 26(1-2):196-8. PubMed ID: 2496589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
    Cross AS; Sadoff JC; Kelly N; Bernton E; Gemski P
    J Exp Med; 1989 Jun; 169(6):2021-7. PubMed ID: 2659724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of therapeutic effect of recombinant tumor necrosis factor against B16 mouse melanoma by combination with recombinant interleukin 2.
    Urano K; Habu S; Nishimura T
    Cytokine; 1993 May; 5(3):224-9. PubMed ID: 8218934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tun T; Fukumoto M; Tobe T
    Biotherapy; 1991; 3(4):337-44. PubMed ID: 1786197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.